Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2014

Nov 12, 2014

65124_rns_2014-11-12_2b518570-44cb-4e14-a7cc-6c0774ea5566.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

13 November 2014

==> picture [170 x 55] intentionally omitted <==

Imugene Limited ACN 009 179 551

ASX RELEASE

Suite 1, 1233 High Street Armadale VIC 3142

On-Sale Cleansing Notice – Issue of Placement Shares

On 12 November 2014, Imugene Limited ACN 009 179 551 (ASX: IMU) ( Imugene ) issued 210 million fully paid ordinary shares at a price of $0.01 to raise $2.10 million ( Shares ) by way of a placement to institutional and sophisticated investors ( Placement ), as outlined in Imugene’s announcement dated Wednesday, 5 November 2014.

Imugene has issued the shares without disclosure to investors under section 708A(5) Corporations Act 2001 (Cth) ( Corporations Act ).

Details of the securities issued

Class of securities Ordinary shares
ASX Code of the securities IMU
Date of the issue or expected issue of thesecurities Wednesday, 12 November 2014
Total number of securities issued orexpected to be issued 210 million

As required by section 708A(6) Corporations Act, Imugene advises:

  • 1 the shares were issued without disclosure to investors under part 6D.2 of the Corporations Act;

  • 2 this notice is given under section 708A(5)(e) of the Corporations Act;

  • 3 at the date of this notice, Imugene has complied with:

    • (a) the provisions of chapter 2M Corporations Act as they apply to Imugene; and

    • (b) section 674 of the Corporations Act;

  • 4 as at the date of this notice, there is no ‘excluded information’ (within the meaning of sections 708A(7) and 708A(8) Corporations Act).

For and on behalf of the Board of Imugene Limited.

==> picture [57 x 54] intentionally omitted <==

Justyn Stedwell Joint Company Secretary Imugene Limited

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com